Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Don B Sanders

Showing results (31-40 of 73) with videos related to

Pageof 8
Sort By:
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 30, 2024
Characteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor/tezacaftor/ivacaftorDon B Sanders, Nicole Mayer-Hamblett, Margaret Rosenfeld, et al.
Annals of the American Thoracic Society|August 20, 2015
Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic FibrosisDon B Sanders, Julia Emerson, Clement L Ren, et al.
American Journal of Respiratory and Critical Care Medicine|May 14, 2010
Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbationDon B Sanders, Rachel C L Bittner, Margaret Rosenfeld, et al.
The European Respiratory Journal|September 3, 2024
Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USAElizabeth A Cromwell, Josh S Ostrenga, Don B Sanders, et al.
Pediatric Pulmonology|June 11, 2015
Risk factors for lung function decline in a large cohort of young cystic fibrosis patientsJonathan Cogen, Julia Emerson, Don B Sanders, et al.
Pediatric Pulmonology|January 8, 2010
Return of FEV1 after pulmonary exacerbation in children with cystic fibrosisDon B Sanders, Lucas R Hoffman, Julia Emerson, et al.
Annals of the American Thoracic Society|November 23, 2013
Risk factors for the progression of cystic fibrosis lung disease throughout childhoodDon B Sanders, Zhanhai Li, Anita Laxova, et al.
Thorax|April 16, 2022
Evaluation of clinically relevant changes in the lung clearance index in children with cystic fibrosis and healthy controlsLucy Perrem, Sanja Stanojevic, Melinda Solomon, et al.
Pediatric Pulmonology|October 14, 2021
Prevalence, variability, and predictors of sinus surgery in pediatric patients with cystic fibrosisFrank W Virgin, Cary Thurm, Don B Sanders, et al.
BMJ Open Respiratory Research|March 27, 2026
Registry-based study of gastrostomy tube placement and nutritional recovery in children with cystic fibrosisBrittany Wall, James E Slaven, Molly A Bozic, et al.
Pageof 8

Showing results (31-40 of 73) with videos related to

Sort By:
Pageof 8
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|July 30, 2024
Characteristics of individuals with cystic fibrosis in the United States ineligible for ivacaftor and elexacaftor/tezacaftor/ivacaftorDon B Sanders, Nicole Mayer-Hamblett, Margaret Rosenfeld, et al.
Annals of the American Thoracic Society|August 20, 2015
Early Childhood Risk Factors for Decreased FEV1 at Age Six to Seven Years in Young Children with Cystic FibrosisDon B Sanders, Julia Emerson, Clement L Ren, et al.
American Journal of Respiratory and Critical Care Medicine|May 14, 2010
Failure to recover to baseline pulmonary function after cystic fibrosis pulmonary exacerbationDon B Sanders, Rachel C L Bittner, Margaret Rosenfeld, et al.
The European Respiratory Journal|September 3, 2024
Impact of the expanded label for elexacaftor/tezacaftor/ivacaftor in people with cystic fibrosis with no F508del variant in the USAElizabeth A Cromwell, Josh S Ostrenga, Don B Sanders, et al.
Pediatric Pulmonology|June 11, 2015
Risk factors for lung function decline in a large cohort of young cystic fibrosis patientsJonathan Cogen, Julia Emerson, Don B Sanders, et al.
Pediatric Pulmonology|January 8, 2010
Return of FEV1 after pulmonary exacerbation in children with cystic fibrosisDon B Sanders, Lucas R Hoffman, Julia Emerson, et al.
Annals of the American Thoracic Society|November 23, 2013
Risk factors for the progression of cystic fibrosis lung disease throughout childhoodDon B Sanders, Zhanhai Li, Anita Laxova, et al.
Thorax|April 16, 2022
Evaluation of clinically relevant changes in the lung clearance index in children with cystic fibrosis and healthy controlsLucy Perrem, Sanja Stanojevic, Melinda Solomon, et al.
Pediatric Pulmonology|October 14, 2021
Prevalence, variability, and predictors of sinus surgery in pediatric patients with cystic fibrosisFrank W Virgin, Cary Thurm, Don B Sanders, et al.
BMJ Open Respiratory Research|March 27, 2026
Registry-based study of gastrostomy tube placement and nutritional recovery in children with cystic fibrosisBrittany Wall, James E Slaven, Molly A Bozic, et al.
Pageof 8